We are live on ! Find out more
GF

Gray Foundation Portfolio holdings

AUM $454M
1-Year Est. Return 38.19%
This Fund
S&P 500
This Quarter Est. Return
+9.6%
1 Year Est. Return
+38.19%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$399M
AUM Growth
+$47.2M
Cap. Flow
+$14.1M
Cap. Flow %
3.54%
Top 10 Hldgs %
99.16%
Holding
11
New
3
Increased
–
Reduced
–
Closed
–
Avg Time Held
5.8 quarters
Top 10 Avg Time Held
6.4 quarters
Top 20 Avg Time Held
5.8 quarters

Top Buys

Rank Stock Value
1
NBIX icon
Neurocrine Biosciences
NBIX
+$5.48M
2
BA icon
Boeing
BA
+$5.43M
3
AZN icon
AstraZeneca
AZN
+$3.2M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 55.12%
2 Miscellaneous 30.06%
3 Communication Services 8.82%
4 Real Estate 2.38%
5 Healthcare 2.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
HLT icon
1
Hilton Worldwide
HLT
$71.4B
$210M 52.74%
731,666
– –
2023 Q4
8 quarters
IGM icon
2
iShares Expanded Tech Sector ETF
IGM
$11.7B
$72.2M 18.12%
559,116
– –
2023 Q4
8 quarters
GOOG icon
3
Alphabet (Google) Class C
GOOG
$4.17T
$35.1M 8.82%
112,000
– –
2023 Q4
8 quarters
INDA icon
4
iShares MSCI India ETF
INDA
$5.78B
$23M 5.77%
425,748
– –
2023 Q4
8 quarters
ROBO icon
5
ROBO Global Robotics & Automation Index ETF
ROBO
$2.08B
$14.2M 3.57%
205,000
– –
2023 Q4
8 quarters
SOXX icon
6
iShares Semiconductor ETF
SOXX
$49.2B
$10.4M 2.6%
34,371
– –
2023 Q4
8 quarters
HGV icon
7
Hilton Grand Vacations
HGV
$2.68B
$9.51M 2.39%
212,520
– –
2023 Q4
8 quarters
INVH icon
8
Invitation Homes
INVH
$15.4B
$9.47M 2.38%
340,734
– –
2023 Q4
8 quarters
BA icon
9
Boeing
BA
$152B
$5.73M 1.44%
+26,400
New +$5.43M
2025 Q4
0 quarters
NBIX icon
10
Neurocrine Biosciences
NBIX
$14.6B
$5.36M 1.35%
+37,800
New +$5.48M
2025 Q4
0 quarters
AZN icon
11
AstraZeneca
AZN
$242B
$3.36M 0.84%
+18,269
New +$3.2M
2025 Q4
0 quarters

Similar funds

Gray Foundation's Q4 2025 Portfolio in Review

As of Q4 2025, Gray Foundation held 11 positions worth $399M, up 13% from $351M the previous quarter. Its ten largest holdings account for 99% of the portfolio.

Gray Foundation deployed $14.1M of net new capital in Q4 2025, opening 3 new positions. Its largest new stake was Neurocrine Biosciences: 37,800 shares worth $5.36M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 55% of assets, down from 57% a quarter earlier, followed by Miscellaneous and Communication Services.

  • Gray Foundation's largest Q4 2025 buy was Neurocrine Biosciences: 37,800 shares worth $5.36M.
  • Gray Foundation's ten largest holdings make up 99% of its $399M portfolio in Q4 2025.
  • Gray Foundation opened 3 new positions and closed 0 in Q4 2025.
  • Gray Foundation's portfolio value rose 13% quarter-over-quarter to $399M.

Based on Gray Foundation's 13F filing for Q4 2025, filed 29 Jan 2026.